- Home
- NKTR vs SLNO Comparison
NKTR vs SLNO Comparison
Compare NKTR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NKTR | SLNO |
|---|---|---|
| Founded | 1990 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NKTR | SLNO |
|---|---|---|
| Price | $81.33 | $52.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $130.00 | $90.13 |
| AVG Volume (30 Days) | 722.9K | ★ 5.5M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 108.90 |
| EPS | N/A | ★ 0.39 |
| Revenue | ★ $307,711,000.00 | $1,450,788.00 |
| Revenue This Year | N/A | $151.77 |
| Revenue Next Year | N/A | $53.58 |
| P/E Ratio | ★ N/A | $134.99 |
| Revenue Growth | 86.00 | ★ 138.82 |
| 52 Week Low | $0.57 | $29.43 |
| 52 Week High | $81.25 | $89.12 |
Technical Indicators
Market Signals| Indicator | NKTR | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 64.63 | 77.58 |
| Support Level | $64.30 | $48.91 |
| Resistance Level | N/A | $55.47 |
| Average True Range (ATR) | 4.75 | 1.49 |
| MACD | 0.37 | 2.06 |
| Stochastic Oscillator | 99.77 | 99.72 |
Price Performance
Historical ComparisonAbout NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.